机器学习归算方法的多度比较与乳腺癌存活率的应用
Imad El Badisy1,2,3, Nathalie Graffeo4, Mohamed Khalis5,6
1Mohammed VI Center For Research and Innovation, Rabat, Morocco. ielbadisy@um6ss.ma.
BMC medical research methodology
|August 30, 2024
概括
机器学习归算方法改善了临床预后研究. 像miceCART和miceRF这样的多重归算 (MI) 方法可以减少偏差,而单一归算 (SI) 方法提供更好的预测准确性,但增加偏差.
科学领域:
- 临床流行病学 临床流行病学
- 生物统计学 生物统计学
- 机器学习应用 机器学习应用
背景情况:
- 在临床预后研究中,处理缺失的数据至关重要.
- 机器学习 (ML) 归算方法提供了潜在的解决方案,但需要进行彻底的评估.
- 现有方法的有效性因分析目标和数据特征而异.
研究的目的:
- 综合评估各种ML归算方法的有效性和可靠性.
- 为了比较单次归算 (SI) 和多次归算 (MI) 技术.
- 评估不同性能指标的方法,包括偏差,预测准确度和无模型指标.
主要方法:
- 评估了单次归算 (KNN,missMDA,CART,missForest,missRanger,missCforest) 和多次归算 (miceCART,miceRF) 的方法.
- 利用一个模拟数据集,其中有30%的随机失踪 (MAR) 值和一个真实世界乳腺癌存活率研究.
- 使用Gower距离,估计偏差,预测准确度 (AUC,C指数) 和信心区间覆盖率等指标评估性能.
主要成果:
- 多重归算 (MI) 方法 (miceCART,miceRF) 在回归估计中显示出最少的偏差.
- 单一归算 (SI) 方法 (missMDA,missForest) 证明了Cox模型的更高的预测准确性.
- MI方法提供了最佳的置信区间覆盖,优于完整病例分析 (CCA).
结论:
- 机器学习归算方法通常优于完整案例分析.
- 归算方法的选择 (SI与MI) 取决于优先考虑的是最小化偏差还是最大化预测准确性.
- 在多重归算框架中集成先进的ML算法可以提高时间到事件研究中的研究完整性.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Survival Curves
116
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
116
Truncation in Survival Analysis
179
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
179
The Mantel-Cox Log-Rank Test
334
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
334


